These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Use of dimethyl-dithio-hydantoin in treatment of certain facial neuralgias]. LEMOYNE J Ann Otolaryngol; 1950; 67(8-9):626-8. PubMed ID: 14790443 [No Abstract] [Full Text] [Related]
5. [Treatment of epilepsy with hydantoin preparations]. JANZ D Nervenarzt; 1950 Mar; 21(3):113-9. PubMed ID: 15423634 [No Abstract] [Full Text] [Related]
7. [Value of 3-methyl-5, 5-phenyl-ethyl-hydantoin in therapy of epilepsy]. HOLTZER PA Belg Tijdschr Geneesk; 1952 Sep; 8(18):817-31. PubMed ID: 13008950 [No Abstract] [Full Text] [Related]
8. [Hydantoin therapy in epilepsy]. STRAUCH W Dtsch Gesundheitsw; 1953 May; 8(20):591-601. PubMed ID: 13067813 [No Abstract] [Full Text] [Related]
9. Epilepsy; treatment with new drug; 3-methyl 5,5-phenyl-ethyl-hydantoin (phenantoin). KOZOL HL Am J Psychiatry; 1946 Sep; 103(2):154-8. PubMed ID: 21001983 [No Abstract] [Full Text] [Related]
10. [Our experiences in the treatment of epilepsy with methyl-phenyl-ethyl-hydantoin]. ROGER J; ROGER A Prog Med (Paris); 1958 Feb; 86(4):67. PubMed ID: 13527523 [No Abstract] [Full Text] [Related]
11. Clinical evaluation of 1-methyl-5,5-phenyl-ethyl-hydantoin in the treatment of epilepsy. LIVINGSTON S; PAULI LL; KRAMER I; NAJMABADI A N Engl J Med; 1961 Aug; 265():418-21. PubMed ID: 13762831 [No Abstract] [Full Text] [Related]
12. Spirodon (tetrantoin): a new anticonvulsant of the hydantoin group. PUTNAM TJ; JACOBS J Neurology; 1957 Nov; 7(11):784-8. PubMed ID: 13483836 [No Abstract] [Full Text] [Related]
13. THE TREATMENT OF EPILEPSY WITH METHYLPHENYLETHYL HYDANTOIN (MESANTOIN). Aird RB Calif Med; 1948 Mar; 68(3):141-6. PubMed ID: 18731395 [No Abstract] [Full Text] [Related]
14. N-methylated derivatives of barbituric acid, hydantoin and oxazolidinedione used in the treatment of epilepsy. BUTLER TC; WADDELL WJ Neurology; 1958 Apr; 8(Suppl 1):106-12. PubMed ID: 13541627 [No Abstract] [Full Text] [Related]
15. [For hydantoin treatment of epilepsy]. FRANKL VE Wien Z Nervenheilkd Grenzgeb; 1948; 1(2-3):284. PubMed ID: 18933032 [No Abstract] [Full Text] [Related]
16. Mesantoin, a new anticonvulsant in the management of epilepsy; a preliminary report. CARTER HR Rocky Mt Med J; 1947 Aug; 44(8):614-6. PubMed ID: 20255912 [No Abstract] [Full Text] [Related]
17. [Clinical experiences with a new anti-epileptic drug: hydotin (3-methyl-5,5-diphenyl-hydantoin)]. CASTELLUCCIO R Sem Med; 1952 Apr; 100(14):405-8. PubMed ID: 14942571 [No Abstract] [Full Text] [Related]
18. The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin. BUTLER TC J Pharmacol Exp Ther; 1956 Jun; 117(2):160-5. PubMed ID: 13332557 [No Abstract] [Full Text] [Related]
19. Ketogenic and other derivatives of hydantoin as anticonvulsants; further results. ORDWAY GL; PURO HE Stanford Med Bull; 1949 Nov; 7(4):157. PubMed ID: 15394886 [No Abstract] [Full Text] [Related]
20. The metabolic fate of 5-ethyl-1-methyl-5-phenyl hydantoin (1-methylnirvanol) and that of 3,5-diethyl-5-phenyl hydantoin (3-ethylnirvanol). BUTLER TC; WADDELL WJ J Pharmacol Exp Ther; 1959 Nov; 127():171-4. PubMed ID: 13806515 [No Abstract] [Full Text] [Related] [Next] [New Search]